NO20062616L - Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder - Google Patents
Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoderInfo
- Publication number
- NO20062616L NO20062616L NO20062616A NO20062616A NO20062616L NO 20062616 L NO20062616 L NO 20062616L NO 20062616 A NO20062616 A NO 20062616A NO 20062616 A NO20062616 A NO 20062616A NO 20062616 L NO20062616 L NO 20062616L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- treatment methods
- new compounds
- compositions
- matching compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
Det beskrives en ny, krystallinsk form av topotecanmonohydrokloridpentahydrat. Forbindelsen er et pentahydrat av 10-[(dimetylamino)metyl]-4-etyl-4,9-dihydroksy-1H-pyranol[3',4': 6,7]indolizino[1,2-b]kinolin-3,14(4H,12H)dionmonohydroklorid. Videre beskrives farmasøytiske preparater, fremstillingsmetoder og/eller bruk derav for å behandle antivirale og/eller cancerrelaterte sykdommer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51916003P | 2003-11-12 | 2003-11-12 | |
US52457403P | 2003-11-24 | 2003-11-24 | |
PCT/US2004/037626 WO2005046608A2 (en) | 2003-11-12 | 2004-11-12 | Novel compound, corresponding compositions, preparation and/or treatment methods |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062616L true NO20062616L (no) | 2006-07-12 |
Family
ID=34594951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062616A NO20062616L (no) | 2003-11-12 | 2006-06-07 | Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder |
Country Status (16)
Country | Link |
---|---|
US (2) | US7754733B2 (no) |
EP (1) | EP1689400A4 (no) |
JP (1) | JP2007510751A (no) |
KR (1) | KR20060122847A (no) |
CN (1) | CN1913897B (no) |
AR (1) | AR046579A1 (no) |
AU (1) | AU2004289318B2 (no) |
BR (1) | BRPI0416366A (no) |
CA (1) | CA2545876A1 (no) |
IL (1) | IL175369A (no) |
IS (1) | IS8491A (no) |
MA (1) | MA28179A1 (no) |
NO (1) | NO20062616L (no) |
RU (1) | RU2352572C2 (no) |
TW (1) | TWI333492B (no) |
WO (1) | WO2005046608A2 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR046579A1 (es) * | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica |
EP1943253A1 (en) | 2005-10-10 | 2008-07-16 | Cipla Limited | Novel crystalline forms |
US7547785B2 (en) * | 2005-12-26 | 2009-06-16 | Dr. Reddy's Laboratories Limited | Process for preparing topotecan |
US7977483B2 (en) * | 2007-04-11 | 2011-07-12 | Scinopharm Taiwan, Ltd. | Process for making topotecan |
NZ580516A (en) * | 2007-04-19 | 2012-02-24 | Scinopharm Taiwan Ltd | Crystalline forms of topotecan hydrochloride and processes for making the same |
US7572803B2 (en) * | 2007-10-25 | 2009-08-11 | The Christus Stehlin Foundation For Cancer Research | Hydrated crystalline esters of camptothecin |
ITMI20072268A1 (it) | 2007-12-04 | 2009-06-05 | Antibioticos Spa | Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione |
WO2023220641A2 (en) | 2022-05-11 | 2023-11-16 | Juno Therapeutics, Inc. | Methods and uses related to t cell therapy and production of same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JP2848958B2 (ja) * | 1990-09-28 | 1999-01-20 | スミスクライン・ビーチャム・コーポレイション | 水溶性カンプトテシン類似体、方法および手段 |
AR013261A1 (es) * | 1997-08-01 | 2000-12-13 | Smithkline Beecham Corp | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina |
HUP0401912A3 (en) * | 2001-09-25 | 2007-02-28 | Reddys Lab Ltd Dr | Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them |
US7049322B2 (en) * | 2002-02-21 | 2006-05-23 | Supergen, Inc. | Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
AR046579A1 (es) * | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica |
EP1943253A1 (en) * | 2005-10-10 | 2008-07-16 | Cipla Limited | Novel crystalline forms |
US7547785B2 (en) * | 2005-12-26 | 2009-06-16 | Dr. Reddy's Laboratories Limited | Process for preparing topotecan |
NZ580516A (en) | 2007-04-19 | 2012-02-24 | Scinopharm Taiwan Ltd | Crystalline forms of topotecan hydrochloride and processes for making the same |
ITMI20072268A1 (it) * | 2007-12-04 | 2009-06-05 | Antibioticos Spa | Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione |
-
2004
- 2004-11-10 AR ARP040104146A patent/AR046579A1/es not_active Application Discontinuation
- 2004-11-10 TW TW093134191A patent/TWI333492B/zh not_active IP Right Cessation
- 2004-11-12 US US10/578,660 patent/US7754733B2/en active Active
- 2004-11-12 KR KR1020067009179A patent/KR20060122847A/ko not_active Application Discontinuation
- 2004-11-12 JP JP2006539849A patent/JP2007510751A/ja active Pending
- 2004-11-12 RU RU2006120422/04A patent/RU2352572C2/ru not_active IP Right Cessation
- 2004-11-12 BR BRPI0416366-4A patent/BRPI0416366A/pt not_active IP Right Cessation
- 2004-11-12 CA CA002545876A patent/CA2545876A1/en not_active Abandoned
- 2004-11-12 WO PCT/US2004/037626 patent/WO2005046608A2/en active Application Filing
- 2004-11-12 EP EP04810731A patent/EP1689400A4/en not_active Withdrawn
- 2004-11-12 AU AU2004289318A patent/AU2004289318B2/en not_active Ceased
- 2004-11-12 CN CN2004800403007A patent/CN1913897B/zh not_active Expired - Fee Related
-
2006
- 2006-05-01 IL IL175369A patent/IL175369A/en not_active IP Right Cessation
- 2006-05-24 MA MA29057A patent/MA28179A1/fr unknown
- 2006-05-30 IS IS8491A patent/IS8491A/is unknown
- 2006-06-07 NO NO20062616A patent/NO20062616L/no not_active Application Discontinuation
-
2010
- 2010-04-30 US US12/770,898 patent/US8158645B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0416366A (pt) | 2007-03-13 |
TWI333492B (en) | 2010-11-21 |
RU2006120422A (ru) | 2007-12-27 |
KR20060122847A (ko) | 2006-11-30 |
US8158645B2 (en) | 2012-04-17 |
AU2004289318B2 (en) | 2010-04-29 |
EP1689400A4 (en) | 2006-12-27 |
CN1913897A (zh) | 2007-02-14 |
AR046579A1 (es) | 2005-12-14 |
US20070117832A1 (en) | 2007-05-24 |
WO2005046608A3 (en) | 2005-11-03 |
IL175369A (en) | 2012-03-29 |
JP2007510751A (ja) | 2007-04-26 |
IL175369A0 (en) | 2008-04-13 |
US7754733B2 (en) | 2010-07-13 |
WO2005046608B1 (en) | 2005-12-29 |
RU2352572C2 (ru) | 2009-04-20 |
AU2004289318A1 (en) | 2005-05-26 |
CA2545876A1 (en) | 2005-05-26 |
TW200530250A (en) | 2005-09-16 |
MA28179A1 (fr) | 2006-09-01 |
IS8491A (is) | 2006-05-30 |
WO2005046608A2 (en) | 2005-05-26 |
CN1913897B (zh) | 2010-08-11 |
EP1689400A2 (en) | 2006-08-16 |
US20100210677A1 (en) | 2010-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062616L (no) | Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder | |
ATE370138T1 (de) | Neue imidazopyridine und ihre verwendung | |
ATE437872T1 (de) | Proteinkinaseinhibitoren | |
ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
MXPA05012466A (es) | Derivados de quinolina como inhibidores de fosfodiesterasa. | |
NO20051263L (no) | Ny anvendelse av benzotiazolderivater | |
HU0102272D0 (en) | Compositions and methods for stimulating gastrointestinal motilis | |
ECSP055809A (es) | Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4 | |
GB0112348D0 (en) | Compounds | |
EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
WO2000068198A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
AP1564A (en) | Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use. | |
IL156827A (en) | Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease | |
MY133527A (en) | Isoquinoline derivatives | |
HUP0301458A2 (hu) | Benzoxazinonszármazékok, eljárás előállításukra és a vegyületek felhasználása | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
CA2354606A1 (en) | Azabicycloalkane derivatives and therapeutic uses thereof | |
WO2000064874A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
TW200504030A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
ATE390923T1 (de) | Topoisomerase-giftmittel | |
NO20055997L (no) | Diarylmetylidenpiperidinderivater og deres anvendelse som opiodreseptoragonister | |
GB0319037D0 (en) | 7-Azaindole Derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |